메뉴 건너뛰기




Volumn 39, Issue 4, 2012, Pages 563-568

Evolving paradigms for successful molecular imaging of medullary thyroid carcinoma

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; GALLIUM 68; SUCCIMER;

EID: 84862533083     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-2035-2     Document Type: Review
Times cited : (3)

References (50)
  • 2
    • 58149239805 scopus 로고    scopus 로고
    • Medullary thyroid cancer: Early detection and novel treatments
    • Roman S, Mehta P, Sosa JA. Medullary thyroid cancer: early detection and novel treatments. Curr Opin Oncol. 2009;21: 5-10.
    • (2009) Curr Opin Oncol , vol.21 , pp. 5-10
    • Roman, S.1    Mehta, P.2    Sosa, J.A.3
  • 3
    • 79851513758 scopus 로고    scopus 로고
    • Medullary thyroid cancer: An update of new guidelines and recent developments
    • Wu LS, Roman SA, Sosa JA. Medullary thyroid cancer: an update of new guidelines and recent developments. Curr Opin Oncol. 2011;23: 22-7.
    • (2011) Curr Opin Oncol , vol.23 , pp. 22-27
    • Wu, L.S.1    Roman, S.A.2    Sosa, J.A.3
  • 4
    • 40749092887 scopus 로고    scopus 로고
    • Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma
    • RufiniV, Castaldi P, Treglia G, Perotti G, GrossMD, Al-Nahhas A, et al. Nuclear medicine procedures in the diagnosis and therapy of medullary thyroid carcinoma. Biomed Pharmacother. 2008;62: 139-46.
    • (2008) Biomed Pharmacother , vol.62 , pp. 139-146
    • Rufiniv Castaldi, P.1    Treglia, G.2    Perotti, G.3    Grossmd Al-Nahhas, A.4
  • 5
    • 80051711134 scopus 로고    scopus 로고
    • Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: Fluorodeoxyglucose and nonfluorodeoxyglucose tracers
    • Wong KK, Arabi M, Zerizer I, Al-Nahhas A, Rubello D, GrossMD. Role of positron emission tomography/computed tomography in adrenal and neuroendocrine tumors: fluorodeoxyglucose and nonfluorodeoxyglucose tracers. Nucl Med Commun. 2011;32: 764-81.
    • (2011) Nucl Med Commun , vol.32 , pp. 764-781
    • Wong, K.K.1    Arabi, M.2    Zerizer, I.3    Al-Nahhas, A.4    Rubello, D.5    Gross, M.D.6
  • 7
    • 84862201270 scopus 로고    scopus 로고
    • How to treat a signal? Current basis for RETgenotype- oriented choice of kinase inhibitors for the treatment of medullary thyroid cancer
    • Prazeres H, Torres J, Rodrigues F, Couto JP, Vinagre J, Sobrinho- Simoes M, et al. How to treat a signal? Current basis for RETgenotype- oriented choice of kinase inhibitors for the treatment of medullary thyroid cancer. J Thyroid Res. 2011;2011: 678357.
    • (2011) J Thyroid Res , vol.2011 , pp. 678357
    • Prazeres, H.1    Torres, J.2    Rodrigues, F.3    Couto, J.P.4    Vinagre, J.5    Sobrinho- Simoes, M.6
  • 8
    • 77955393886 scopus 로고    scopus 로고
    • The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors
    • Ye L, Santarpia L, Gagel RF. The evolving field of tyrosine kinase inhibitors in the treatment of endocrine tumors. Endocr Rev. 2010;31: 578-99.
    • (2010) Endocr Rev , vol.31 , pp. 578-599
    • Ye, L.1    Santarpia, L.2    Gagel, R.F.3
  • 9
    • 67749130797 scopus 로고    scopus 로고
    • Medullary thyroid cancer: Management guidelines of the American Thyroid Association
    • Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid. 2009;19: 565-612.
    • (2009) Thyroid , vol.19 , pp. 565-612
    • Kloos, R.T.1    Eng, C.2    Evans, D.B.3    Francis, G.L.4    Gagel, R.F.5    Gharib, H.6
  • 10
    • 78649924923 scopus 로고    scopus 로고
    • Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A?
    • discussion 1309-10
    • Grubbs EG, Waguespack SG, Rich TA, Xing Y, Ying AK, Evans DB, et al. Do the recent American Thyroid Association (ATA) Guidelines accurately guide the timing of prophylactic thyroidectomy in MEN2A? Surgery. 2010;148: 1302-9. discussion 1309-10.
    • (2010) Surgery , vol.148 , pp. 1302-1309
    • Grubbs, E.G.1    Waguespack, S.G.2    Rich, T.A.3    Xing, Y.4    Ying, A.K.5    Evans, D.B.6
  • 12
    • 4844221091 scopus 로고    scopus 로고
    • Role of CT/111In-octreotide SPECT digital fusion imaging in the localization of loco-regional recurrence of medullary thyroid carcinoma
    • Fiore D, Rubello D, Casara D, Pelizzo MR, Franchi A, Muzzio PC. Role of CT/111In-octreotide SPECT digital fusion imaging in the localization of loco-regional recurrence of medullary thyroid carcinoma. Minerva Chir. 2004;59: 295-9.
    • (2004) Minerva Chir , vol.59 , pp. 295-299
    • Fiore, D.1    Rubello, D.2    Casara, D.3    Pelizzo, M.R.4    Franchi, A.5    Muzzio, P.C.6
  • 15
    • 0031668864 scopus 로고    scopus 로고
    • Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological indings
    • Adams S, Baum RP, Hertel A, Schumm-Draeger PM, Usadel KH, Hor G. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological indings. Eur J Nucl Med. 1998;25: 1277-83.
    • (1998) Eur J Nucl Med , vol.25 , pp. 1277-1283
    • Adams, S.1    Baum, R.P.2    Hertel, A.3    Schumm-Draeger, P.M.4    Usadel, K.H.5    Hor, G.6
  • 16
    • 0034756055 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: Results of a multicentre study
    • Diehl M, Risse JH, Brandt-Mainz K, Dietlein M, Bohuslavizki KH, Matheja P, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med. 2001;28: 1671-6.
    • (2001) Eur J Nucl Med , vol.28 , pp. 1671-1676
    • Diehl, M.1    Risse, J.H.2    Brandt-Mainz, K.3    Dietlein, M.4    Bohuslavizki, K.H.5    Matheja, P.6
  • 18
    • 36849090954 scopus 로고    scopus 로고
    • Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy
    • Oudoux A, Salaun PY, Bournaud C, Campion L, Ansquer C, Rousseau C, et al. Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy. J Clin Endocrinol Metab. 2007;92: 4590-7.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 4590-4597
    • Oudoux, A.1    Salaun, P.Y.2    Bournaud, C.3    Campion, L.4    Ansquer, C.5    Rousseau, C.6
  • 19
    • 34248594179 scopus 로고    scopus 로고
    • Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated alcitonin levels
    • Ong SC, Schoder H, Patel SG, Tabangay-Lim IM, Doddamane I, Gonen M, et al. Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated alcitonin levels. J Nucl Med. 2007;48: 501-7.
    • (2007) J Nucl Med , vol.48 , pp. 501-507
    • Ong, S.C.1    Schoder, H.2    Patel, S.G.3    Tabangay-Lim, I.M.4    Doddamane, I.5    Gonen, M.6
  • 20
    • 41949099184 scopus 로고    scopus 로고
    • The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective tudy
    • Rubello D, Rampin L, Nanni C, Banti E, Ferdeghini M, Fanti S, et al. The role of 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective tudy. Eur J Surg Oncol. 2008;34: 581-6.
    • (2008) Eur J Surg Oncol , vol.34 , pp. 581-586
    • Rubello, D.1    Rampin, L.2    Nanni, C.3    Banti, E.4    Ferdeghini, M.5    Fanti, S.6
  • 22
    • 78049336593 scopus 로고    scopus 로고
    • The prognostic value of 2-deoxy-2-[18F] fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma
    • Bogsrud TV, Karantanis D, Nathan MA, Mullan BP,Wiseman GA, Kasperbauer JL, et al. The prognostic value of 2-deoxy-2-[18F] fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma. Mol Imaging Biol. 2010;12: 547-53.
    • (2010) Mol Imaging Biol , vol.12 , pp. 547-553
    • Bogsrud, T.V.1    Karantanis, D.2    Nathan, M.A.3    Mullan, B.P.4    Wiseman, G.A.5    Kasperbauer, J.L.6
  • 23
    • 0033625019 scopus 로고    scopus 로고
    • Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific ositioning labeling in positron emission tomography
    • Sundin A, Eriksson B, Bergstrom M, Bjurling P, Lindner KJ, Oberg K, et al. Demonstration of [11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific ositioning labeling in positron emission tomography. Nucl Med Biol. 2000;27: 33-41.
    • (2000) Nucl Med Biol , vol.27 , pp. 33-41
    • Sundin, A.1    Eriksson, B.2    Bergstrom, M.3    Bjurling, P.4    Lindner, K.J.5    Oberg, K.6
  • 24
    • 0021047386 scopus 로고
    • Striatal dopamine metabolism in living monkeys examined by positron emission tomography
    • Garnett S, Firnau G, Nahmias C, Chirakal R. Striatal dopamine metabolism in living monkeys examined by positron emission tomography. Brain Res. 1983;280: 169-71.
    • (1983) Brain Res , vol.280 , pp. 169-171
    • Garnett, S.1    Firnau, G.2    Nahmias, C.3    Chirakal, R.4
  • 25
    • 0027018649 scopus 로고
    • Uptake and utilization of [beta-11C]5-hydroxytryptophan in human brain studied by positron emission tomography
    • Reibring L,Agren H,Hartvig P, Tedroff J, Lundqvist H, Bjurling P, et al. Uptake and utilization of [beta-11C]5-hydroxytryptophan in human brain studied by positron emission tomography. Psychiatry Res. 1992;45: 215-25.
    • (1992) Psychiatry Res , vol.45 , pp. 215-225
    • Reibring, L.1    Agren, H.2    Hartvig, P.3    Tedroff, J.4    Lundqvist, H.5    Bjurling, P.6
  • 26
    • 0034746433 scopus 로고    scopus 로고
    • 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
    • Hoegerle S, Altehoefer C, Ghanem N, Brink I, Moser E, Nitzsche E. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med. 2001;28: 64-71.
    • (2001) Eur J Nucl Med , vol.28 , pp. 64-71
    • Hoegerle, S.1    Altehoefer, C.2    Ghanem, N.3    Brink, I.4    Moser, E.5    Nitzsche, E.6
  • 27
    • 67349208753 scopus 로고    scopus 로고
    • The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: Comparison with 18F-FDG PETCT
    • Beheshti M, Pocher S, Vali R, Waldenberger P, Broinger G, Nader M, et al. The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PETCT. Eur Radiol. 2009;19: 1425-34.
    • (2009) Eur Radiol , vol.19 , pp. 1425-1434
    • Beheshti, M.1    Pocher, S.2    Vali, R.3    Waldenberger, P.4    Broinger, G.5    Nader, M.6
  • 28
    • 34748868457 scopus 로고    scopus 로고
    • Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-Omethyl- 6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma
    • Beuthien-Baumann B, Strumpf A, Zessin J, Bredow J, Kotzerke J. Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-Omethyl- 6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2007;34: 1604-9.
    • (2007) Eur J Nucl Med Mol Imaging , vol.34 , pp. 1604-1609
    • Beuthien-Baumann, B.1    Strumpf, A.2    Zessin, J.3    Bredow, J.4    Kotzerke, J.5
  • 29
    • 65549141729 scopus 로고    scopus 로고
    • The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors
    • Kauhanen S, Seppanen M, Ovaska J, Minn H, Bergman J, Korsoff P, et al. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors. Endocr Relat Cancer. 2009;16: 255-65.
    • (2009) Endocr Relat Cancer , vol.16 , pp. 255-265
    • Kauhanen, S.1    Seppanen, M.2    Ovaska, J.3    Minn, H.4    Bergman, J.5    Korsoff, P.6
  • 30
    • 42049103697 scopus 로고    scopus 로고
    • 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: Elation to tumor differentiation
    • Koopmans KP, de Groot JW, Plukker JT, de Vries EG, Kema IP, Sluiter WJ, et al. 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: elation to tumor differentiation. J Nucl Med. 2008;49: 524-31.
    • (2008) J Nucl Med , vol.49 , pp. 524-531
    • Koopmans, K.P.1    De Groot, J.W.2    Plukker, J.T.3    De Vries, E.G.4    Kema, I.P.5    Sluiter, W.J.6
  • 31
    • 77949270173 scopus 로고    scopus 로고
    • Dual PET/CT with (18) F-DOPA and (18) FFDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging
    • Marzola MC, Pelizzo MR, Ferdeghini M, Toniato A, Massaro A, Ambrosini V, et al. Dual PET/CT with (18) F-DOPA and (18) FFDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging. Eur J Surg Oncol. 2010;36: 414-21.
    • (2010) Eur J Surg Oncol , vol.36 , pp. 414-421
    • Marzola, M.C.1    Pelizzo, M.R.2    Ferdeghini, M.3    Toniato, A.4    Massaro, A.5    Ambrosini, V.6
  • 32
    • 77949273307 scopus 로고    scopus 로고
    • Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA ET/CT) for detecting pheochromocytoma
    • Luster M, KargesW, Zeich K, Pauls S, Verburg FA, Dralle H, et al. Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA ET/CT) for detecting pheochromocytoma. Eur J Nucl Med Mol Imaging. 2010;37: 484-93.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , pp. 484-493
    • Luster, M.1    Kargesw Zeich, K.2    Pauls, S.3    Verburg, F.A.4    Dralle, H.5
  • 34
    • 77952340573 scopus 로고    scopus 로고
    • Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma
    • Luster M, Karges W, Zeich K, Pauls S, Verburg FA, Dralle H, et al. Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. Thyroid. 2010;20: 527-33.
    • (2010) Thyroid , vol.20 , pp. 527-533
    • Luster, M.1    Karges, W.2    Zeich, K.3    Pauls, S.4    Verburg, F.A.5    Dralle, H.6
  • 36
    • 84859795319 scopus 로고    scopus 로고
    • Sequential 18F-FDG and 18-F-DOPA PET/CT in recurrent medullary thyroid cancer (MTC)
    • Marzola MC, Ferdeghini M, Rampin L, Banti L, Grassetto G, Cittadin S, et al. Sequential 18F-FDG and 18-F-DOPA PET/CT in recurrent medullary thyroid cancer (MTC) . J Nucl Med. 2010;51 Suppl 2: 71.
    • (2010) J Nucl Med , vol.51 , Issue.SUPPL. 2 , pp. 71
    • Marzola, M.C.1    Ferdeghini, M.2    Rampin, L.3    Banti, L.4    Grassetto, G.5    Cittadin, S.6
  • 37
    • 77953928471 scopus 로고    scopus 로고
    • The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy
    • Srirajaskanthan R, Kayani I, Quigley AM, Soh J, Caplin ME, Bomanji J. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy. J Nucl Med. 2010;51: 875-82.
    • (2010) J Nucl Med , vol.51 , pp. 875-882
    • Srirajaskanthan, R.1    Kayani, I.2    Quigley, A.M.3    Soh, J.4    Caplin, M.E.5    Bomanji, J.6
  • 39
    • 0035726431 scopus 로고    scopus 로고
    • Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid
    • Papotti M, Kumar U, Volante M, Pecchioni C, Patel YC. Immunohistochemical detection of somatostatin receptor types 1-5 in medullary carcinoma of the thyroid. Clin Endocrinol Oxf. 2001;54: 641-9.
    • (2001) Clin Endocrinol Oxf , vol.54 , pp. 641-649
    • Papotti, M.1    Kumar, U.2    Volante, M.3    Pecchioni, C.4    Patel, Y.C.5
  • 40
    • 36749090076 scopus 로고    scopus 로고
    • Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: A phase II clinical trial
    • Iten F, Muller B, Schindler C, Rochlitz C, Oertli D,Macke HR, et al. Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial. Clin Cancer Res. 2007;13: 6696-702.
    • (2007) Clin Cancer Res , vol.13 , pp. 6696-6702
    • Iten, F.1    Muller, B.2    Schindler, C.3    Rochlitz, C.4    Oertli Dmacke, H.R.5
  • 41
    • 78650564928 scopus 로고    scopus 로고
    • Localization of medullary thyroid carcinoma after surgery using (11) C-methionine PET/CT: Comparison with (18) F-FDG PET/CT
    • Jang HW, Choi JY, Lee JI, Kim HK, Shin HW, Shin JH, et al. Localization of medullary thyroid carcinoma after surgery using (11) C-methionine PET/CT: comparison with (18) F-FDG PET/CT. Endocr J. 2010;57: 1045-54.
    • (2010) Endocr J , vol.57 , pp. 1045-1054
    • Jang, H.W.1    Choi, J.Y.2    Lee, J.I.3    Kim, H.K.4    Shin, H.W.5    Shin, J.H.6
  • 42
    • 77953239940 scopus 로고    scopus 로고
    • The surgical management of medullary thyroid cancer
    • Dackiw AP. The surgical management of medullary thyroid cancer. Otolaryngol Clin North Am. 2010;43: 365-74.
    • (2010) Otolaryngol Clin North Am , vol.43 , pp. 365-374
    • Dackiw, A.P.1
  • 43
    • 77957947626 scopus 로고    scopus 로고
    • Molecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancers
    • Tai D, Poon D. Molecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancers. J Oncol. 2011;2011: pii 398564
    • (2011) J Oncol , vol.2011 , pp. 398564
    • Tai, D.1    Poon, D.2
  • 44
    • 77955214443 scopus 로고    scopus 로고
    • The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: Pheochromocytoma, paraganglioma, and medullary thyroid cancer
    • Chen H, Sippel RS, O'Dorisio MS, Vinik AI, Lloyd RV, Pacak K. The North American Neuroendocrine Tumor Society consensus guideline for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas. 2010;39: 775-83
    • (2010) Pancreas , vol.39 , pp. 775-783
    • Chen, H.1    Sippel, R.S.2    O'Dorisio, M.S.3    Vinik, A.I.4    Lloyd, R.V.5    Pacak, K.6
  • 45
    • 79251524248 scopus 로고    scopus 로고
    • Alternative therapeutic approaches in the treatment of primary and secondary dedifferentiated and medullary thyroid carcinoma
    • Biermann K, Biersack HJ, Sabet A, Janzen V. Alternative therapeutic approaches in the treatment of primary and secondary dedifferentiated and medullary thyroid carcinoma. Semin Nucl Med. 2011;41: 139-48.
    • (2011) Semin Nucl Med , vol.41 , pp. 139-148
    • Biermann, K.1    Biersack, H.J.2    Sabet, A.3    Janzen, V.4
  • 46
    • 79960906082 scopus 로고    scopus 로고
    • Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer
    • Divgi C. Targeted systemic radiotherapy of pheochromocytoma and medullary thyroid cancer. Semin Nucl Med. 2011;41: 369-73.
    • (2011) Semin Nucl Med , vol.41 , pp. 369-373
    • Divgi, C.1
  • 47
    • 79959742655 scopus 로고    scopus 로고
    • Updates in the management of medullary thyroid cancer
    • Hu MI. Updates in the management of medullary thyroid cancer. Clin Adv Hematol Oncol. 2011;9: 391-4.
    • (2011) Clin Adv Hematol Oncol , vol.9 , pp. 391-394
    • Hu, M.I.1
  • 48
    • 66149139452 scopus 로고    scopus 로고
    • From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors
    • Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1: 122S-50S.
    • (2009) J Nucl Med , vol.50 , Issue.SUPPL. 1
    • Wahl, R.L.1    Jacene, H.2    Kasamon, Y.3    Lodge, M.A.4
  • 50
    • 79957707824 scopus 로고    scopus 로고
    • Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: A useful tool for patient risk stratification
    • Mian C, Pennelli G, Barollo S, Cavedon E, Nacamulli D, Vianello F, et al. Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification. Eur J Endocrinol. 2011;164: 971-6.
    • (2011) Eur J Endocrinol , vol.164 , pp. 971-976
    • Mian, C.1    Pennelli, G.2    Barollo, S.3    Cavedon, E.4    Nacamulli, D.5    Vianello, F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.